Simple Summary In chronic lymphocytic leukemia (CLL), immune alterations—affecting both
the innate and adaptive immunity—are very common. As a clinical consequence, patients …

Patients with chronic lymphocyticleukemia (CLL) typically have innate/adaptive immune
system dysregulation, thus the protective effect of coronavirus disease 2019 (COVID-19) …

Chronic lymphocytic leukaemia (CLL) is associated with immunocompromise and high risk
of severe COVID‐19 disease and mortality. Monoclonal B‐cell lymphocytosis (MBL) patients …

We studied clinical and immunological outcome of Covid-19 in consecutive CLL patients
from a well-defined area during month 1–13 of the pandemic. Sixty patients (median age 71 …

This national Israeli multicenter retrospective study aimed to characterize the clinical course
of COVID-19 infection among patients with hematological malignancies, with special …

Patients treated with B-cell-targeting therapies like Rituximab or Ibrutinib have decreased
serological response to various vaccines. In this study, we tested serological and cellular …

Patients with lymphoproliferative diseases (LPD) are vulnerable to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection. Here, we describe and analyze the …

Significance between time points with missing values was assessed using Kruskal-Wallis
test with Dunn's posttest. Correlation analysis was done using non-parametric Spearman …

Simple Summary The severe acute respiratory syndrome coronavirus (SARS-CoV-2) has
become the cause of a worldwide pandemic, and its clinical infection course in patients with …

Background COVID-19 has been extensively characterized in immunocompetent hosts and
to a lesser extent in immunocompromised populations. Among the latter, patients treated for …